UK report calls for cooperation on population genotyping
BMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7185.692c (Published 13 March 1999) Cite this as: BMJ 1999;318:692- Tessa Richards
- BMJ
The government must work with the pharmaceutical industry, healthcare providers, insurance companies, and the public to define the policy issues posed by the rapid advances in genetics and to agree terms under which population genotyping might proceed, according to a report from the School of Public Policy in London.
Currently, public policy lags behind the science, and the social and ethical issues posed by widespread genotyping, particularly with respect to the privacy and confidentiality of genetic data, are not being actively confronted. Meanwhile, the pace is being set-as the recent …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £164 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.